A pharmaceutical composition comprising a pharmaceutically acceptable salt of [2-(3-fluoro-5-methanesulfonylphenoxy)ethyl](propyl)amine, and a pharmaceutical drug for Parkinson's disease, and uses of said pharmaceutical composition

A pharmaceutical composition comprising a pharmaceutically acceptable salt of [2-(3-fluoro-5-methanesulfonylphenoxy)ethyl](propyl)amine, and a pharmaceutical drug for Parkinson's disease, and uses of said pharmaceutical composition

The invention provides a compound of Formula I, or a pharmaceutically acceptable salt thereof, for use in the prevention or reduction of sensitization to a pharmaceutical drug for Parkinson's disease. The invention further provides a compound of Formula I or a pharmaceutically acceptable salt t...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: SVENNINGSSON, PER, TEDROFF, JOAKIM MIHKEL, HOLM WATERS, SUSANNA
Format: Patent
Sprache:chi ; eng
Schlagworte:
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The invention provides a compound of Formula I, or a pharmaceutically acceptable salt thereof, for use in the prevention or reduction of sensitization to a pharmaceutical drug for Parkinson's disease. The invention further provides a compound of Formula I or a pharmaceutically acceptable salt thereof, for use in optimization of the dosage of a pharmaceutical drug for Parkinson's disease (e.g. L-DOPA or a pharmaceutically acceptable salt thereof).